|
|
|
|
| LEADER |
03447nam a22004695i 4500 |
| 001 |
978-3-319-22602-6 |
| 003 |
DE-He213 |
| 005 |
20210617105032.0 |
| 007 |
cr nn 008mamaa |
| 008 |
151002s2015 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783319226026
|9 978-3-319-22602-6
|
| 024 |
7 |
|
|a 10.1007/978-3-319-22602-6
|2 doi
|
| 050 |
|
4 |
|a R-RZ
|
| 072 |
|
7 |
|a MBGR
|2 bicssc
|
| 072 |
|
7 |
|a MED000000
|2 bisacsh
|
| 072 |
|
7 |
|a MBGR
|2 thema
|
| 082 |
0 |
4 |
|a 610
|2 23
|
| 245 |
1 |
0 |
|a Anticoagulation Management
|h [electronic resource] :
|b A Guidebook for Pharmacists /
|c edited by Anne Rose.
|
| 250 |
|
|
|a 1st ed. 2015.
|
| 264 |
|
1 |
|a Cham :
|b Springer International Publishing :
|b Imprint: Adis,
|c 2015.
|
| 300 |
|
|
|a XVI, 274 p. 40 illus., 7 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 505 |
0 |
|
|a 1. Inpatient Warfarin Management -- 2. Ambulatory Warfarin Management -- 3. Unfractionated Heparin and Low Molecular Weight Heparin -- 4. Direct Oral Anticoagulants -- 5. Anticoagulation Reversal -- 6. Prevention of Venous Thromboembolism -- 7. Treatment of Venous Thromboembolism -- 8. Periprocedural Anticoagulation -- 9. Heparin Induced Thrombocytopenia -- 10. Anticoagulation Management in the Emergency Department -- 11. Anticoagulation Stewardship.
|
| 520 |
|
|
|a In addition to acting as a training guide for pharmacists, pharmacy residents and pharmacy students who seek to practice in areas associated with patients on anticoagulant therapy, the information presented within highlights the growing role of the pharmacist in these contexts. Readers will find useful information on anticoagulant management across all pharmacy practice areas, including the inpatient, ambulatory, emergency services and transitions of care settings. Particular attention is given to summarizing best practices and providing ‘real world’ examples of ways in which pharmacists can be involved in anticoagulation management and the impact of such involvement. In the first major section of the book, each chapter focuses on the role of the pharmacist in the management of medication with a specific type of anticoagulants (e.g. warfarin, heparin and target-specific oral agents) in various healthcare settings. A broader overview of the clinical management of anticoagulation therapy is provided in the second major section, including descriptions of the role of pharmacists in assessing venous thromboembolism risk, ensuring patients receive appropriate prophylactic therapy, and monitoring outcomes.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Pharmacotherapy.
|
| 650 |
1 |
4 |
|a Biomedicine, general.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/B0000X
|
| 650 |
2 |
4 |
|a Pharmacotherapy.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/H69000
|
| 700 |
1 |
|
|a Rose, Anne.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer Nature eBook
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783319226019
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783319226033
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783319372334
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-319-22602-6
|
| 912 |
|
|
|a ZDB-2-SBL
|
| 912 |
|
|
|a ZDB-2-SXB
|
| 950 |
|
|
|a Biomedical and Life Sciences (SpringerNature-11642)
|
| 950 |
|
|
|a Biomedical and Life Sciences (R0) (SpringerNature-43708)
|
